CPDU On Other Exchanges

china pediatric pharmaceutic (CPDU) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

china pediatric pharmaceutic (CPDU) Related Businessweek News

No Related Businessweek News Found

china pediatric pharmaceutic (CPDU) Details

China Pediatric Pharmaceuticals, Inc., through its subsidiaries, identifies, discovers, develops, manufactures, and distributes prescription and over-the counter pharmaceutical products for the treatment of various diseases and conditions in the People’s Republic of China. It provides Cooers brand products that focus on the pediatric medicine market, which addresses various ailments, including pain relief, anti-inflammatory, anti-bacteria, infection, digestion, respiratory tract infections, gangrene, diarrhea and fever, cold and cough remedies, and vitamins. The company also provides Qingsongling brand product line in the adult market for the treatment of heart disease and angina, respiratory tract infection, influenza, gangrene, anti-inflammatory pain relief, cold and fever remedies, and vitamins. In addition, it offers Xianzhi brand product line that focuses on the adult medicine market to treat chronic bronchitis and asthma. The company is based in Xi’an, the People's Republic of China.

135 Employees
Last Reported Date: 04/15/14

china pediatric pharmaceutic (CPDU) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

china pediatric pharmaceutic
SEC Revokes Registration Of Registered Securities Of China Pediatric Pharmaceuticals, Inc

"An Administrative Law Judge has issued an Initial Decision of Default as to China Pediatric Pharmaceuticals, Inc. The Initial Decision found that the company was issuer of securities registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (Exchange Act), and the company failed to comply with Section 13(a) of the Exchange Act and Exchange Act Rules 13a-1 and/or 13a-13 by not filing required periodic reports with the Securities and Exchange Commission (SEC). The Initial Decision finds these allegations to be true and revokes the registration of each class of the company’s registered securities, pursuant to Section 12(j) of the Securities Exchange Act of 1934. "

SEC Orders Hearings On Registration Suspension Or Revocation Against China Pediatric Pharmaceuticals, Inc. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of China Pediatric Pharmaceuticals, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CPDU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CPDU.
View Industry Companies

Industry Analysis


Industry Average

Valuation CPDU Industry Range
Price/Earnings 0.2x
Price/Sales 0.1x
Price/Book 0.0x
Price/Cash Flow 0.2x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHINA PEDIATRIC PHARMACEUTIC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.